Akebia Therapeutics Inc (AKBA)
1.155
+0.02
(+1.32%)
USD |
NASDAQ |
May 17, 16:00
1.155
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Total Long Term Debt (Quarterly): 30.14M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 30.14M |
| December 31, 2023 | 34.68M |
| September 30, 2023 | 42.61M |
| June 30, 2023 | 42.49M |
| March 31, 2023 | 50.30M |
| December 31, 2022 | 66.08M |
| September 30, 2022 | 65.95M |
| June 30, 2022 | 98.16M |
| March 31, 2022 | 97.85M |
| December 31, 2021 | 97.54M |
| September 30, 2021 | 97.23M |
| June 30, 2021 | 96.92M |
| March 31, 2021 | 96.61M |
| December 31, 2020 | 96.38M |
| September 30, 2020 | 76.61M |
| Date | Value |
|---|---|
| June 30, 2020 | 76.34M |
| March 31, 2020 | 76.07M |
| December 31, 2019 | 75.80M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 15.00M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
98.16M
Maximum
Jun 2022
65.89M
Average
75.94M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 28.78M |
| Amicus Therapeutics Inc | 388.39M |
| Insmed Inc | 1.163B |
| Altimmune Inc | 0.00 |
| InfuSystems Holdings Inc | 29.93M |